Brain Cancer

Showing NaN - NaN of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)

Recruiting
  • Brain Cancer
  • +4 more
  • Trastuzumab deruxtecan
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 22, 2023

Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)

Recruiting
  • Glioma
  • +7 more
  • Laparoscopically harvested omental tissue autograft
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 31, 2023

Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial

Recruiting
  • Glioma, Malignant
  • +6 more
  • Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 13, 2023

Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

Recruiting
  • Glioblastoma
  • +8 more
  • Intra-arterial Cetuximab
  • +2 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 17, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Brain Cancer Trial in United States (Optune (NovoTTF-100A))

Active, not recruiting
  • Brain Cancer
  • Optune (NovoTTF-100A)
  • Los Angeles, California
  • +8 more
Jul 1, 2022

Brain Cancer Trial in United States (MK-3475)

Completed
  • Brain Cancer
  • Los Angeles, California
  • +6 more
Jun 6, 2022

Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

Active, not recruiting
  • Glioblastoma Multiforme
  • +6 more
  • Dendritic cell immunotherapy
  • Birmingham, Alabama
  • +85 more
May 12, 2022

Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in New York (Repeated Superselective Intraarterial Cerebral

Recruiting
  • Glioblastoma
  • +6 more
  • Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation
  • Temozolomide and Radiation Alone
  • New York, New York
    Lenox Hill Brain Tumor Center
May 5, 2022

Brain Cancer Trial in New York (PET scan, C-Choline)

Completed
  • Brain Cancer
  • PET scan
  • C-Choline
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 9, 2022

Brain Cancer Trial in Worldwide (Nivolumab, Temozolomide, Radiotherapy)

Completed
  • Brain Cancer
  • Birmingham, Alabama
  • +124 more
Mar 16, 2022

Diffusion and Perfusion MRI in Patients With Brain Metastasis

Active, not recruiting
  • Brain Cancer
  • MRI
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 15, 2022

Brain Cancer Trial in Canada, United States (cetuximab in conjunction with external beam radiation therapy, followed by

Completed
  • Brain Cancer
  • cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan
  • Phoenix, Arizona
  • +11 more
Mar 2, 2022

Brain Cancer Trial in New York (preoperative fMRI. DTI and DSI with tractography)

Active, not recruiting
  • Brain Cancer
  • preoperative fMRI. DTI and DSI with tractography
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 1, 2022

Brain Cancer, Pituitary Adenoma Trial in New York (89Zr-DFO-cRGDY-PEG-Cy5-C' dots PET Imaging, Blood and Urine samples)

Recruiting
  • Brain Cancer
  • Pituitary Adenoma
  • 89Zr-DFO-cRGDY-PEG-Cy5-C' dots PET Imaging
  • Blood and Urine samples
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2022

Coping With Glioblastoma: A Study of Communication Between

Active, not recruiting
  • Brain Cancer
  • Glioblastoma
  • psychometric tests, questionnaires and neurocognitive assessments
  • Detroit, Michigan
  • +7 more
Dec 16, 2021

Glioblastoma, Brain Cancer, Brain Tumor Trial in New York (Intra-arterial Cetuximab, Intra-arterial Mannitol)

Recruiting
  • Glioblastoma
  • +6 more
  • Intra-arterial Cetuximab
  • Intra-arterial Mannitol
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 27, 2021

Glioblastoma, Glioblastoma Multiforme, GBM Trial in New York (Tissue autograft of pedicled temporoparietal fascial (TPF) or

Recruiting
  • Glioblastoma
  • +3 more
  • Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 27, 2021

PET and MRI Imaging of Brain Tumors Using [18F]PARPi

Recruiting
  • Brain Tumor
  • Brain Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 21, 2021

Brain Cancer, Glioma Trial in New York (MRI and advanced MRI sequences)

Recruiting
  • Brain Cancer
  • Glioma
  • MRI and advanced MRI sequences
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 1, 2021

Glioblastoma Multiforme (GBM), Glioblastoma, Glioma of Brain Trial in New York (Capecitabine, Temozolomide)

Recruiting
  • Glioblastoma Multiforme (GBM)
  • +8 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Aug 30, 2021

Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)

Completed
  • Brain Cancer
  • +10 more
  • DNX-2401
  • pembrolizumab
  • Little Rock, Arkansas
  • +14 more
Jul 13, 2021

Brain Cancer Trial in Basking Ridge, Commack, New York (erlotinib, Cytoreductive Surgery)

Completed
  • Brain Cancer
  • Basking Ridge, New Jersey
  • +3 more
Jan 6, 2021

Brain Cancer, Glioma Trial in New York (18F-FLT PET Scan)

Completed
  • Brain Cancer
  • Glioma
  • 18F-FLT PET Scan
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Nov 20, 2020

Brain Cancer, CNS Cancer Trial in New York (FACBC, Methionine, PET Scan)

Completed
  • Brain Cancer
  • CNS Cancer
  • FACBC, Methionine
  • PET Scan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 20, 2020